Relapsed Acute Lymphoblastic Leukemia (ALL) Active Not Recruiting Phase 1 / 2 Trials for Fludarabine (DB01073)
Also known as: Acute Lymphoblastic Leukemia, in Relapse / Relapsed ALL / Relapsed Acute Lymphoblastic Leukemia / Acute, relapsed Lymphoblastic Leukemia
| Indication | Status | Phase |
|---|---|---|
| DBCOND0069491 (Relapsed Acute Lymphoblastic Leukemia (ALL)) | Active Not Recruiting | 1 / 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03573700 | Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia | Treatment |